Disposable Medical Device Sensors Market

Executive Summary

Disposable Medical Device Sensors Market was valued at US $7.05 billion in 2021 and is projected to grow at 8.39% CAGR over the forecast period to reach US $11.42 billion by 2027. Disposable Medical Device Sensors Market represented US $1.05 billion opportunity over 2019-2021 and estimated to create US $4.38 billion opportunity in 2027 over 2021.

Disposable Medical Device Sensors from Consainsights analyses the Disposable Medical Device Sensors Market in the Life Sciences industry over the forecast period to 2027.

Disposable Medical Device Sensors research report from Consainsights outlines the detailed strategic analysis, trends, market opportunities, growth prospects, industry and market challenges and sustainable solutions to sustain in the competitive environment.

Disposable Medical Device Sensors segmentation includes Product, Placement Of Sensors, Application and Geography.

Based on the Product, the Disposable Medical Device Sensors analysis covers Biosensors, Pressure Sensors, Accelerometers, Temperature Sensors, Image Sensors, Other Sensors.

In Product segment, Biosensors segment has highest cagr growth of 7.42%.

Based on the Placement Of Sensors, the Disposable Medical Device Sensors analysis covers Strip Sensors, Wearable Sensors, Implantable Sensors, Invasive Sensors, Ingestible Sensors.

In Placement Of Sensors segment, Strip Sensors segment has highest cagr growth of 7.42%.

Based on the Application, the Disposable Medical Device Sensors analysis covers Diagnostic Testing Devices, Therapeutic Devices, Patient Monitoring Devices, Imaging Devices.

In Application segment, Diagnostic Testing Devices segment has highest cagr growth of 7.42%.

Based on the region, the Disposable Medical Device Sensors analysis covers North America, Europe, Asia-Pacific, Middle-East & Africa, Latin America.

Key companies operating in the market include Medtronic Plc, Stmicroelectronics N.V., Honeywell International, Inc., Te Connectivity, Smiths Medical, Ge Healthcare, Philips Healthcare, Freescale Semiconductor, Inc., Analog Devices, Inc., Omnivision Technologies Inc. and so on. This report covers the detailed analysis of the company profiles such as business segments, product portfolio, key brand insights and growth strategies adopted, company SWOT and Strategy analysis along with the financial analysis and analyst insights on the key companies operating in this market.

Market Overview

Definition & Scope

The base currency considered was the US Dollar (USD). Conversion of other currencies to USD was considered on the basis of the average exchange rate for the respective review-period years. The exchange rate conversion for forecast period was determined according to the base year’s conversion rates.

The base year was identified based on the availability of annual reports and secondary information. The base year considered for this study is 2027.

The review period considered for this study is from 2018-2027. The CAGR is for the forecast period, 2022-2027.

Market size estimations for the forecast years were in real terms. Inflation is not part of the pricing, and the average selling price (ASP) was kept constant throughout the forecast period for each country.

Distribution of primary interviews conducted was based on the regional share of the market and the presence of key players in each region.

As a result of data triangulation through multiple methodologies and approaches, the weighted averages of resulting estimates were considered to be the final values.

Currency, Year & Forecast

The currency used in this report is USD, with the market size indicated in terms of USD million/billion.

For companies reporting their revenues in USD, the revenues were taken from their respective annual reports/SEC filings.

For companies reporting their revenues in other currencies, the average annual currency conversion rates were used for a particular year to convert the value to USD Market Definition.

Product

Introduction

In 2021, Biosensors segment has the highest revenue of US $2.89 billion and is expected to grow at CAGR of 7.42% by 2027 Biosensors segment has highest cagr growth of 7.42%.

Biosensors

Biosensors segment was valued at US $2.46 billion in 2019 and is projected to grow at 7.42% CAGR over the forecast period to reach US $4.69 billion by 2027. Biosensors segment represented US $0.43 billion opportunity over 2019-2021 and estimated to create US $1.80 billion opportunity in 2027 over 2021.

Pressure Sensors

Pressure Sensors segment was valued at US $1.27 billion in 2019 and is projected to grow at 7.42% CAGR over the forecast period to reach US $2.42 billion by 2027. Pressure Sensors segment represented US $0.22 billion opportunity over 2019-2021 and estimated to create US $0.93 billion opportunity in 2027 over 2021.

Accelerometers

Accelerometers segment was valued at US $1.07 billion in 2019 and is projected to grow at 7.42% CAGR over the forecast period to reach US $2.04 billion by 2027. Accelerometers segment represented US $0.19 billion opportunity over 2019-2021 and estimated to create US $0.78 billion opportunity in 2027 over 2021.

Temperature Sensors

Temperature Sensors segment was valued at US $0.45 billion in 2019 and is projected to grow at 7.42% CAGR over the forecast period to reach US $0.86 billion by 2027. Temperature Sensors segment represented US $0.08 billion opportunity over 2019-2021 and estimated to create US $0.33 billion opportunity in 2027 over 2021.

Image Sensors

Image Sensors segment was valued at US $0.40 billion in 2019 and is projected to grow at 7.42% CAGR over the forecast period to reach US $0.75 billion by 2027. Image Sensors segment represented US $0.07 billion opportunity over 2019-2021 and estimated to create US $0.29 billion opportunity in 2027 over 2021.

Other Sensors

Other Sensors segment was valued at US $0.35 billion in 2019 and is projected to grow at 7.42% CAGR over the forecast period to reach US $0.66 billion by 2027. Other Sensors segment represented US $0.06 billion opportunity over 2019-2021 and estimated to create US $0.25 billion opportunity in 2027 over 2021.

Placement Of Sensors

Introduction

In 2021, Strip Sensors segment has the highest revenue of US $3.34 billion and is expected to grow at CAGR of 7.42% by 2027 Strip Sensors segment has highest cagr growth of 7.42%.

Strip Sensors

Strip Sensors segment was valued at US $2.84 billion in 2019 and is projected to grow at 7.42% CAGR over the forecast period to reach US $5.41 billion by 2027. Strip Sensors segment represented US $0.50 billion opportunity over 2019-2021 and estimated to create US $2.07 billion opportunity in 2027 over 2021.

Wearable Sensors

Wearable Sensors segment was valued at US $1.54 billion in 2019 and is projected to grow at 7.42% CAGR over the forecast period to reach US $2.94 billion by 2027. Wearable Sensors segment represented US $0.27 billion opportunity over 2019-2021 and estimated to create US $1.12 billion opportunity in 2027 over 2021.

Implantable Sensors

Implantable Sensors segment was valued at US $0.81 billion in 2019 and is projected to grow at 7.42% CAGR over the forecast period to reach US $1.54 billion by 2027. Implantable Sensors segment represented US $0.14 billion opportunity over 2019-2021 and estimated to create US $0.59 billion opportunity in 2027 over 2021.

Invasive Sensors

Invasive Sensors segment was valued at US $0.77 billion in 2019 and is projected to grow at 7.42% CAGR over the forecast period to reach US $1.46 billion by 2027. Invasive Sensors segment represented US $0.13 billion opportunity over 2019-2021 and estimated to create US $0.56 billion opportunity in 2027 over 2021.

Ingestible Sensors

Ingestible Sensors segment was valued at US $0.04 billion in 2019 and is projected to grow at 7.42% CAGR over the forecast period to reach US $0.07 billion by 2027. Ingestible Sensors segment represented US $0.01 billion opportunity over 2019-2021 and estimated to create US $0.03 billion opportunity in 2027 over 2021.

Application

Introduction

In 2021, Diagnostic Testing Devices segment has the highest revenue of US $3.05 billion and is expected to grow at CAGR of 7.42% by 2027 Diagnostic Testing Devices segment has highest cagr growth of 7.42%.

Diagnostic Testing Devices

Diagnostic Testing Devices segment was valued at US $2.60 billion in 2019 and is projected to grow at 7.42% CAGR over the forecast period to reach US $4.95 billion by 2027. Diagnostic Testing Devices segment represented US $0.45 billion opportunity over 2019-2021 and estimated to create US $1.90 billion opportunity in 2027 over 2021.

Therapeutic Devices

Therapeutic Devices segment was valued at US $1.53 billion in 2019 and is projected to grow at 7.42% CAGR over the forecast period to reach US $2.91 billion by 2027. Therapeutic Devices segment represented US $0.27 billion opportunity over 2019-2021 and estimated to create US $1.11 billion opportunity in 2027 over 2021.

Patient Monitoring Devices

Patient Monitoring Devices segment was valued at US $1.53 billion in 2019 and is projected to grow at 7.42% CAGR over the forecast period to reach US $2.91 billion by 2027. Patient Monitoring Devices segment represented US $0.27 billion opportunity over 2019-2021 and estimated to create US $1.12 billion opportunity in 2027 over 2021.

Imaging Devices

Imaging Devices segment was valued at US $0.34 billion in 2019 and is projected to grow at 7.42% CAGR over the forecast period to reach US $0.65 billion by 2027. Imaging Devices segment represented US $0.06 billion opportunity over 2019-2021 and estimated to create US $0.25 billion opportunity in 2027 over 2021.